Illness	Number of cases
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	70
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	69
Hyperplasia of prostate (N40)	43
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	42
Malignant neoplasm of prostate (C61)	23
Calculus of kidney and ureter - Calculus of kidney (N20.0)	21
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	20
Calculus of kidney and ureter - Calculus of ureter (N20.1)	19
Acute tubulo-interstitial nephritis (N10)	18
Cystitis (N30.2)	16

Top 10 treatments

Treatment	Number
(5-98k.0)	147
Injection or administration of medicines into the urinary bladder (8-132.3)	136
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	103
Injection or administration of medicines into the urinary bladder (8-132.2)	96
Injection or administration of medicines into the urinary bladder (8-132.x)	92
Insertion, exchange or removal of a ureteral stent (8-137.00)	71
Insertion, exchange or removal of a ureteral stent (8-137.10)	71
(9-984.7)	68
Computed tomography (CT) of the abdomen without contrast medium (3-207)	59
(9-984.8)	57

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
41	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
37	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
37	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility